Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis

Table 1

Characteristics of the included studies.

Author	Design (country)	Settings	Period of data collection (days)	Sample size	Gender		Age	Survived	Deaths	STROBE score
					Male	Female
Chen et al. [17]	RC (China)	Zhongnan Hospital and the Seventh Hospital of Wuhan city	45	123	61	62	57.79 ± 15.32	92	31	19
Du et al. [25]	RC (China)	Wuhan Pulmonary Hospital	43	179	97	82	57.60 ± 13.70	158	21	16
Guo et al. [18]	RC (China)	The Seventh Hospital, Wuhan	31	187	91	96	58.50 ± 14.66	144	43	20
Li et al. [19]	RC (China)	Tongji Hospital, Wuhan	35	102	59	43	57.25 ± 4.99	87	15	15
Luo et al. [20]	RC (China)	Eastern Campus of Renmin Hospital, Wuhan	27	403	193	210	54.75 ± 4.90	303	100	20
Ruan et al. [21]	RC (China)	Medical Records of NHC and China CDC	NA	150	102	48	56.82 ± 10.95	82	68	13
Shi et al. [22]	RC (China)	Renmin Hospital, Wuhan	21	416	205	211	61.00 ± 12.47	359	57	20
Zhang et al. [23]	RC (China)	Wuhan No. 1 Hospital	52	48	33	15	64.03 ± 16.54	31	17	17
Zhou et al. [24]	RC (China)	Jinyintan Hospital and Wuhan Pulmonary Hospital	33	191	119	72	56.25 ± 3.86	137	54	20

RC, retrospective cohort.